Multiple Myeloma

News

CHMP backs generic lenalidomide

The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended approval for Lenalidomide Accord as a...

MD IQ

News

Global burden of hematologic malignancies

Research has shown an increase in the global incidence of leukemia and non-Hodgkin lymphoma (NHL) in recent years. The Global Burden of Disease (...

News

FDA approves biosimilar filgrastim

The US Food and Drug Administration (FDA) has approved the leukocyte growth factor Nivestym™ (filgrastim-aafi), a biosimilar to Neupogen (...

Pages